Tejara Capital’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
873,381
+27,160
| +3% | +$381K | 5.68% | 2 |
|
|
2025
Q1 | $13.2M | Sell |
846,221
-40,617
| -5% | -$635K | 5.11% | 1 |
|
|
2024
Q4 | $12.4M | Sell |
886,838
-278,471
| -24% | -$3.88M | 8.09% | 1 |
|
|
2024
Q3 | $10.8M | Sell |
1,165,309
-178,300
| -13% | -$1.66M | 5.16% | 3 |
|
|
2024
Q2 | $12.5M | Buy |
1,343,609
+403,122
| +43% | +$3.75M | 4.54% | 3 |
|
|
2024
Q1 | $9.32M | Sell |
940,487
-171,730
| -15% | -$1.7M | 3.42% | 7 |
|
|
2023
Q4 | $3.59M | Buy |
1,112,217
+803,038
| +260% | +$2.59M | 1.5% | 25 |
|
|
2023
Q3 | $1.64M | Buy |
309,179
+145,000
| +88% | +$770K | 0.93% | 32 |
|
|
2023
Q2 | $1.56M | Buy |
164,179
+66,179
| +68% | +$631K | 0.77% | 34 |
|
|
2023
Q1 | $1.08M | Buy |
98,000
+40,000
| +69% | +$440K | 0.55% | 44 |
|
|
2022
Q4 | $858K | Buy |
+58,000
| New | +$858K | 0.49% | 48 |
|